[
  {
    "title": "Sample and Data Relationship Format for Proteomics (SDRF-Proteomics)",
    "content": "// suppress inspection \"GrazieInspection\" for whole file\nSample and Data Relationship Format for Proteomics (SDRF-Proteomics)\n\n//only works on some backends, not HTML\n\n//use style like Section 1 when referencing within the document.\n\n//GitHub specific settings\n\nStatus of this document\n\nThis document provides information to the proteomics community about a proposed standard for sample metadata annotations in public repositories called Sample and Data Relationship File (SDRF)-Proteomics format. Distribution is unlimited.\n\nVersion v1.1.0 - 2025-08-13\n\nAbstract\n\nThe Human Proteome Organisation (HUPO) Proteomics Standards Initiative (PSI) defines community standards for data representation in proteomics to facilitate data comparison, exchange, and verification. This document presents a specification for the Sample and Data Relationship Format (SDRF-Proteomics).\n\nFurther detailed information, including any updates to this document, implementations, and examples is available at SDRF GitHub Repository. The official PSI web page for the document is the following: \n\nMotivation\n\nMany resources have emerged that provide raw or integrated proteomics data in the public domain. If these are valuable individually, their integration through re-analysis represents a huge asset for the community [1].\n\nUnfortunately, proteomics experimental design and sample related information are often missing in public repositories or stored in very diverse ways and formats. For example:\n\n- The CPTAC Consortium provides for every dataset a set of Excel files with the information on each sample including tumor size, origin, but also how every sample is related to a specific raw file (e.g. instrument configuration parameters).\n\n- As a resource routinely re-analysing public datasets, ProteomicsDB, captures for each sample in the database a minimum number of properties to describe the sample and the related experimental protocol such as tissue, digestion method and instrument.\n\nSuch heterogeneity often ",
    "url": "./specification.html",
    "section": "Core Specification",
    "keywords": "EXPRESS CT SILAC FITNESS USE MHC IS cleavage agent details MINOR MAY THE NOT PP ZFA SHOULD INFRINGE VK JA III CLO HUPO CF XML fractionation method MOD MT IMPORTANT OR mass biosample accession number PEPTIDESEQ PMID CPTAC PRM disease stage ... depletion ROW data file IAA EW LC URI SN OPTIONAL SHALL LIMITED CID CN ANY sample IMPLIED instrument SRM REQUIRES spiked compound INCLUDING RAW TAB TMT EFO HANCESTRO HCD INITIATIVE THAT dissociation method STANDARDS DDA AS exclamation replicate INFORMATION PRIDE:0000659 PSI label PATO BTO IDF PMCID XL organism part sex README biological replicate NT TIP PARTICULAR FDR DTT HF URL proteomics data acquisition method RFC PURPOSE organism SP ALL HTML LI DJ ISA BE BRENDA RECOMMEND ENVO RIGHTS pooled sample COULD BUT source name CL QY TO SH RECOMMENDED MERCHANTABILITY REQUIRED cell type DISCLAIMS fraction identifier PATCH age PRIDE ID HEREIN MC WARRANTIES PROTEOMICS EM disease MANDATORY MAGE MUST developmental stage collision energy FOR alkylation reagent UBERON COLUMN MONDO MS WILL source name_ and _assay name NCE WARRANTY II OF AC PO PS PTM file your EBI reduction reagent CS MIAME NCBI SDRF BMC MAJOR CV SWATH technical replicate characteristics DIA NOTE CELL MS:1001251 individual TA DOID ancestry category"
  },
  {
    "title": "Sample and Data Relationship Format for Proteomics (SDRF-Proteomics)",
    "content": "// suppress inspection \"GrazieInspection\" for whole file\nSample and Data Relationship Format for Proteomics (SDRF-Proteomics)\n\n//only works on some backends, not HTML\n\n//use style like Section 1 when referencing within the document.\n\n//GitHub specific settings\n\nStatus of this document\n\nThis document provides information to the proteomics community about a proposed standard for sample metadata annotations in public repositories called Sample and Data Relationship File (SDRF)-Proteomics format. Distribution is unlimited.\n\nVersion v1.1.0 - 2025-08-13\n\nAbstract\n\nThe Human Proteome Organisation (HUPO) Proteomics Standards Initiative (PSI) defines community standards for data representation in proteomics to facilitate data comparison, exchange, and verification. This document presents a specification for the Sample and Data Relationship Format (SDRF-Proteomics).\n\nFurther detailed information, including any updates to this document, implementations, and examples is available at SDRF GitHub Repository. The official PSI web page for the document is the following: \n\nMotivation\n\nMany resources have emerged that provide raw or integrated proteomics data in the public domain. If these are valuable individually, their integration through re-analysis represents a huge asset for the community [1].\n\nUnfortunately, proteomics experimental design and sample related information are often missing in public repositories or stored in very diverse ways and formats. For example:\n\n- The CPTAC Consortium provides for every dataset a set of Excel files with the information on each sample including tumor size, origin, but also how every sample is related to a specific raw file (e.g. instrument configuration parameters).\n\n- As a resource routinely re-analysing public datasets, ProteomicsDB, captures for each sample in the database a minimum number of properties to describe the sample and the related experimental protocol such as tissue, digestion method and instrument.\n\nSuch heterogeneity often ",
    "url": "./specification.html#sample-and-data-relationship-format-for-proteomics-sdrf-proteomics",
    "section": "Core Specification",
    "keywords": "EXPRESS CT SILAC FITNESS USE MHC IS cleavage agent details MINOR MAY THE NOT PP ZFA SHOULD INFRINGE VK JA III CLO HUPO CF fractionation method MOD MT OR mass biosample accession number PEPTIDESEQ PMID CPTAC PRM disease stage ... depletion ROW data file IAA EW LC URI SN OPTIONAL SHALL LIMITED CID CN ANY IMPLIED instrument SRM REQUIRES spiked compound INCLUDING RAW TAB TMT EFO HANCESTRO HCD INITIATIVE THAT dissociation method STANDARDS DDA AS INFORMATION PRIDE:0000659 PSI label PATO BTO IDF PMCID XL organism part sex README biological replicate NT PARTICULAR FDR DTT HF URL proteomics data acquisition method RFC PURPOSE organism SP ALL HTML LI DJ ISA BE BRENDA RECOMMEND ENVO RIGHTS pooled sample COULD BUT CL QY TO SH RECOMMENDED MERCHANTABILITY REQUIRED cell type DISCLAIMS fraction identifier PATCH age PRIDE HEREIN MC WARRANTIES PROTEOMICS EM disease MANDATORY MAGE MUST collision energy FOR alkylation reagent UBERON COLUMN MONDO MS WILL NCE WARRANTY II OF AC PO PS PTM EBI reduction reagent CS MIAME NCBI SDRF BMC MAJOR CV SWATH technical replicate DIA CELL MS:1001251 individual TA DOID ancestry category"
  },
  {
    "title": "Sample Metadata Conventions",
    "content": "Sample Metadata Conventions\n\nStatus of this Convention\n\nThis document provides guidelines for annotating general sample metadata in SDRF-Proteomics format. These conventions apply to samples from any organism (human, animal, plant).\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nSample metadata conventions define standardized formats for common properties that apply across all organism types. This convention covers:\n\n- Organism annotation\n- Organism part / tissue annotation\n- Age and temporal information\n- Biological sex\n- Disease and health status\n- Developmental stage\n- Cell type annotation\n\nFor human-specific metadata (disease staging, comorbidities, treatment history, demographics, lifestyle factors), see Human Sample Metadata Convention.\n\nOrganism Annotation\n\nColumn\n\ncharacteristics[organism]\n\nOntology\n\n- Primary: NCBI Taxonomy (NCBITaxon)\n- Alternative: EFO\n\nFormat\n\nUse the scientific name in lowercase:\n\nValue |NCBITaxon ID |Description\n\nhomo sapiens\nNCBITaxon:9606\nHuman\n\nmus musculus\nNCBITaxon:10090\nMouse\n\nrattus norvegicus\nNCBITaxon:10116\nRat\n\ndanio rerio\nNCBITaxon:7955\nZebrafish\n\ndrosophila melanogaster\nNCBITaxon:7227\nFruit fly\n\ncaenorhabditis elegans\nNCBITaxon:6239\nNematode worm\n\nsaccharomyces cerevisiae\nNCBITaxon:4932\nBaker's yeast\n\narabidopsis thaliana\nNCBITaxon:3702\nThale cress\n\n Use lowercase for organism names. The validator will map to the correct ontology term.\n\nOrganism Part / Tissue Annotation\n\nColumn\n\ncharacteristics[organism part]\n\nOntologies\n\nOrganism Type |Ontology |URL\n\nMammals/Vertebrates\nUBERON\n\nPlants\nPlant Ontology (PO)\n\nDrosophila\nFlyBase Anatomy (FBbt)\n\nC. elegans\nWormBase Anatomy (WBbt)\n\nCommon Values\n\nValue |UBERON ID |Description\n\nblood\nUBERON:0000178\nWhole blood\n\nblood plasma\nUBERON:0001969\nPlasma fraction\n\nblood serum\nUBERON:0001977\nSerum fraction\n\nliver\nUBERON:0002107\nLiver tissue\n\nbrain\nUBERON:0000955\nBrain tissue\n\nheart\nUBERON:0000948\nHeart tissue\n\nkidney\nUBERON:0002113\nKidney tissue\n\nlung\nUBERON:0002048\nLung tissue\n\nskin\nUBERON:0002097\nSk",
    "url": "./conventions/sample-metadata.html",
    "section": "Sample Metadata Convention",
    "keywords": "CL:0000182 MONDO:0005105 xenograft CML CL:0000623 MONDO:0008383 NK MAY SHOULD UBERON:0002048 UBERON:0001155 PATO:0000461 MONDO:0004946 IMPORTANT UBERON:0002113 CL:0000624 UBERON:0000310 depletion MONDO:0005301 UBERON:0002107 CL:0000898 PATO:0001340 CL:0000815 CL:0000540 MONDO:0100096 COVID disease model EFO HANCESTRO UBERON:0002097 CL:0000576 exclamation MONDO:0005148 UBERON:0000178 PATO NSG organism part DSS PATO:0000383 sex CL:0000788 APP biological replicate TIP PDX CL:0000233 CL:0000057 URL UBERON:0000948 organism ALL UBERON:0001969 CL:0000913 CL:0000236 enrichment process source name CL UBERON:0000955 CL:0000625 UBERON:0001088 cell type CL:0000813 PATO:0000384 UBERON:0001359 age compound CL:0000235 CL:0000232 ID CL:0000787 disease MUST developmental stage CSF UBERON MONDO CL:0000451 CL:0000084 PO PTM NCBI SDRF MONDO:0004989 MONDO:0004975 MONDO:0005180 NOTE synthetic peptide individual CL:0000066 lib UBERON:0001977 MONDO:0005575 MONDO:0005138 DOID ancestry category"
  },
  {
    "title": "Sample Metadata Conventions",
    "content": "Sample Metadata Conventions\n\nStatus of this Convention\n\nThis document provides guidelines for annotating general sample metadata in SDRF-Proteomics format. These conventions apply to samples from any organism (human, animal, plant).\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nSample metadata conventions define standardized formats for common properties that apply across all organism types. This convention covers:\n\n- Organism annotation\n- Organism part / tissue annotation\n- Age and temporal information\n- Biological sex\n- Disease and health status\n- Developmental stage\n- Cell type annotation\n\nFor human-specific metadata (disease staging, comorbidities, treatment history, demographics, lifestyle factors), see Human Sample Metadata Convention.\n\nOrganism Annotation\n\nColumn\n\ncharacteristics[organism]\n\nOntology\n\n- Primary: NCBI Taxonomy (NCBITaxon)\n- Alternative: EFO\n\nFormat\n\nUse the scientific name in lowercase:\n\nValue |NCBITaxon ID |Description\n\nhomo sapiens\nNCBITaxon:9606\nHuman\n\nmus musculus\nNCBITaxon:10090\nMouse\n\nrattus norvegicus\nNCBITaxon:10116\nRat\n\ndanio rerio\nNCBITaxon:7955\nZebrafish\n\ndrosophila melanogaster\nNCBITaxon:7227\nFruit fly\n\ncaenorhabditis elegans\nNCBITaxon:6239\nNematode worm\n\nsaccharomyces cerevisiae\nNCBITaxon:4932\nBaker's yeast\n\narabidopsis thaliana\nNCBITaxon:3702\nThale cress\n\n Use lowercase for organism names. The validator will map to the correct ontology term.\n\nOrganism Part / Tissue Annotation\n\nColumn\n\ncharacteristics[organism part]\n\nOntologies\n\nOrganism Type |Ontology |URL\n\nMammals/Vertebrates\nUBERON\n\nPlants\nPlant Ontology (PO)\n\nDrosophila\nFlyBase Anatomy (FBbt)\n\nC. elegans\nWormBase Anatomy (WBbt)\n\nCommon Values\n\nValue |UBERON ID |Description\n\nblood\nUBERON:0000178\nWhole blood\n\nblood plasma\nUBERON:0001969\nPlasma fraction\n\nblood serum\nUBERON:0001977\nSerum fraction\n\nliver\nUBERON:0002107\nLiver tissue\n\nbrain\nUBERON:0000955\nBrain tissue\n\nheart\nUBERON:0000948\nHeart tissue\n\nkidney\nUBERON:0002113\nKidney tissue\n\nlung\nUBERON:0002048\nLung tissue\n\nskin\nUBERON:0002097\nSk",
    "url": "./conventions/sample-metadata.html#sample-metadata-conventions",
    "section": "Sample Metadata Convention",
    "keywords": "CL:0000182 MONDO:0005105 xenograft CML CL:0000623 MONDO:0008383 NK MAY SHOULD UBERON:0002048 UBERON:0001155 PATO:0000461 MONDO:0004946 UBERON:0002113 CL:0000624 UBERON:0000310 depletion MONDO:0005301 UBERON:0002107 CL:0000898 PATO:0001340 CL:0000815 CL:0000540 MONDO:0100096 COVID disease model EFO HANCESTRO UBERON:0002097 CL:0000576 MONDO:0005148 UBERON:0000178 PATO NSG organism part DSS PATO:0000383 sex CL:0000788 APP biological replicate PDX CL:0000233 CL:0000057 URL UBERON:0000948 organism ALL UBERON:0001969 CL:0000913 CL:0000236 enrichment process source name CL UBERON:0000955 CL:0000625 UBERON:0001088 cell type CL:0000813 PATO:0000384 UBERON:0001359 age compound CL:0000235 CL:0000232 ID CL:0000787 disease MUST developmental stage CSF UBERON MONDO CL:0000451 CL:0000084 PO PTM NCBI SDRF MONDO:0004989 MONDO:0004975 MONDO:0005180 synthetic peptide individual CL:0000066 UBERON:0001977 MONDO:0005575 MONDO:0005138 DOID ancestry category"
  },
  {
    "title": "Human Sample Metadata Convention",
    "content": "Human Sample Metadata Convention\n\nStatus of this Convention\n\nThis document provides guidelines for annotating human-specific metadata in SDRF-Proteomics format. These conventions apply to all human samples, including both clinical studies and healthy individuals.\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nHuman-specific metadata is crucial for interpreting proteomics data from human samples, enabling stratification by clinical and demographic characteristics and integration with other biomedical datasets. This convention defines standardized approaches for annotating human-specific metadata:\n\n- Disease staging and grading\n- Pre-existing conditions and comorbidities\n- Treatment and medication history\n- Individual/patient identifiers\n- Additional clinical metadata (BMI, lifestyle factors, reproductive status)\n\nFor general sample metadata conventions (age, biological sex, basic disease annotation) that apply to all organisms, see Sample Metadata Conventions.\n\nDisease Staging and Grading\n\nDisease staging and grading are primarily used for human cancers and other progressive diseases.\n\nDisease Stage\n\nColumn\n\ncharacteristics[disease stage]\n\nOntology\n\n- Primary: NCI Thesaurus (NCIT)\n- Alternative: EFO\n\nStandard Values\n\nValue |NCIT ID |Description\n\nstage I\nNCIT:C27966\nEarly localized disease\n\nstage II\nNCIT:C28054\nLocally advanced\n\nstage III\nNCIT:C27970\nRegional spread\n\nstage IV\nNCIT:C27971\nDistant metastasis\n\nearly\n\nGeneral early stage\n\nadvanced\n\nGeneral advanced stage\n\nlocalized\nNCIT:C68804\nConfined to primary site\n\nmetastatic\nNCIT:C14174\nHas spread to distant sites\n\nnot available\n\nStage unknown\n\nnot applicable\n\nStaging not relevant (non-cancer)\n\nCancer-Specific Staging\n\nTNM Staging\n\nColumn\n\ncharacteristics[TNM staging]\n\nOntology\n\n- Primary: NCI Thesaurus (NCIT)\n\nFormat\n\nT{0-4}N{0-3}M{0-1}\n\nComponents:\n\n- T: Primary tumor size/extent (T0-T4, Tis for in situ)\n- N: Regional lymph node involvement (N0-N3)\n- M: Distant metastasis (M0, M1)\n\nPrefix p indicates pathological staging (e.g",
    "url": "./conventions/human-metadata.html",
    "section": "Human Metadata Convention",
    "keywords": "menopausal status NCI CHEBI:41774 NCIT:C18213 time post treatment NCIT:C28078 weight NCIT:C28077 NCIT:C18206 III NCIT:C53556 Ann Arbor stage MONDO:0005044 IMPORTANT NCIT:C27971 disease stage HIPAA NCIT:C14169 HANCESTRO:0009 PR TNM NCIT:C65108 MONDO:0011122 ER NCIT:C4870 NCIT:C18058 gestational age alcohol consumption NCIT:C28054 HANCESTRO:0010 smoking status NCIT:C53554 EFO HANCESTRO MONDO:0002050 exclamation NCIT:C14168 MONDO:0005148 ACE NCIT:C62723 prior treatment HANCESTRO:0006 tumor grade secondary condition NCIT:C15445 MONDO:0005300 BMI organism part sex NCIT:C15329 NCIT:C15313 NCIT:C81328 UO treatment NCIT:C65107 CHEBI:6801 NCIT:C16358 NCIT:C14167 HANCESTRO:0005 treatment status MONDO:0004995 organism NCIT:C28076 Dukes stage NCIT:C81327 TNM staging NCIT:C15632 NCIT NCIT:C65106 NCIT:C28079 PREFERRED GDPR CHEBI:28748 NCIT:C53553 age pre-existing condition compound ID MONDO:0004979 PD NCIT:C14174 height ethnicity NCIT:C68804 disease diet body mass index NCIT:C15262 MONDO NCIT:C71732 II NCIT:C27966 treatment response CHEBI:27899 dose SDRF NCIT:C27970 NOTE individual sampling time point IV NCIT:C53555 AJCC pregnancy status medication history breast cancer subtype ancestry category"
  },
  {
    "title": "Human Sample Metadata Convention",
    "content": "Human Sample Metadata Convention\n\nStatus of this Convention\n\nThis document provides guidelines for annotating human-specific metadata in SDRF-Proteomics format. These conventions apply to all human samples, including both clinical studies and healthy individuals.\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nHuman-specific metadata is crucial for interpreting proteomics data from human samples, enabling stratification by clinical and demographic characteristics and integration with other biomedical datasets. This convention defines standardized approaches for annotating human-specific metadata:\n\n- Disease staging and grading\n- Pre-existing conditions and comorbidities\n- Treatment and medication history\n- Individual/patient identifiers\n- Additional clinical metadata (BMI, lifestyle factors, reproductive status)\n\nFor general sample metadata conventions (age, biological sex, basic disease annotation) that apply to all organisms, see Sample Metadata Conventions.\n\nDisease Staging and Grading\n\nDisease staging and grading are primarily used for human cancers and other progressive diseases.\n\nDisease Stage\n\nColumn\n\ncharacteristics[disease stage]\n\nOntology\n\n- Primary: NCI Thesaurus (NCIT)\n- Alternative: EFO\n\nStandard Values\n\nValue |NCIT ID |Description\n\nstage I\nNCIT:C27966\nEarly localized disease\n\nstage II\nNCIT:C28054\nLocally advanced\n\nstage III\nNCIT:C27970\nRegional spread\n\nstage IV\nNCIT:C27971\nDistant metastasis\n\nearly\n\nGeneral early stage\n\nadvanced\n\nGeneral advanced stage\n\nlocalized\nNCIT:C68804\nConfined to primary site\n\nmetastatic\nNCIT:C14174\nHas spread to distant sites\n\nnot available\n\nStage unknown\n\nnot applicable\n\nStaging not relevant (non-cancer)\n\nCancer-Specific Staging\n\nTNM Staging\n\nColumn\n\ncharacteristics[TNM staging]\n\nOntology\n\n- Primary: NCI Thesaurus (NCIT)\n\nFormat\n\nT{0-4}N{0-3}M{0-1}\n\nComponents:\n\n- T: Primary tumor size/extent (T0-T4, Tis for in situ)\n- N: Regional lymph node involvement (N0-N3)\n- M: Distant metastasis (M0, M1)\n\nPrefix p indicates pathological staging (e.g",
    "url": "./conventions/human-metadata.html#human-sample-metadata-convention",
    "section": "Human Metadata Convention",
    "keywords": "menopausal status NCI CHEBI:41774 NCIT:C18213 time post treatment NCIT:C28078 weight NCIT:C28077 NCIT:C18206 III NCIT:C53556 Ann Arbor stage MONDO:0005044 NCIT:C27971 disease stage HIPAA NCIT:C14169 HANCESTRO:0009 PR TNM NCIT:C65108 MONDO:0011122 ER NCIT:C4870 NCIT:C18058 gestational age alcohol consumption NCIT:C28054 HANCESTRO:0010 smoking status NCIT:C53554 EFO HANCESTRO MONDO:0002050 NCIT:C14168 MONDO:0005148 ACE NCIT:C62723 prior treatment HANCESTRO:0006 tumor grade secondary condition NCIT:C15445 MONDO:0005300 BMI organism part sex NCIT:C15329 NCIT:C15313 NCIT:C81328 UO treatment NCIT:C65107 CHEBI:6801 NCIT:C16358 NCIT:C14167 HANCESTRO:0005 treatment status MONDO:0004995 organism NCIT:C28076 Dukes stage NCIT:C81327 TNM staging NCIT:C15632 NCIT NCIT:C65106 NCIT:C28079 PREFERRED GDPR CHEBI:28748 NCIT:C53553 age pre-existing condition compound ID MONDO:0004979 PD NCIT:C14174 height ethnicity NCIT:C68804 disease diet body mass index NCIT:C15262 MONDO NCIT:C71732 II NCIT:C27966 treatment response CHEBI:27899 dose SDRF NCIT:C27970 individual sampling time point IV NCIT:C53555 AJCC pregnancy status medication history breast cancer subtype ancestry category"
  },
  {
    "title": "Data File Metadata Conventions",
    "content": "Data File Metadata Conventions\n\nStatus of this Convention\n\nThis document provides guidelines for annotating data file metadata in SDRF-Proteomics format. These conventions define standardized approaches for describing MS run files, instrument settings, and analysis parameters.\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nData file metadata conventions define standardized formats for properties that describe the relationship between samples and data files, instrument configurations, and analysis parameters. This convention covers:\n\n- Assay name and data file identification\n- Label annotations for multiplexed experiments\n- Instrument type and model\n- Technology type\n- Protein modifications\n- Cleavage agents\n- Mass tolerances\n\nFor sample metadata conventions (organism, age, sex, disease), see Sample Metadata Conventions.\n\nCore Data File Columns\n\nThe connection between samples and data files is done using properties annotated with the comment prefix. The use of comment differentiates data file properties from sample properties (characteristics).\n\nColumn Order\n\nThe order of columns is important:\n\n1. assay name SHOULD always be located before the comments\n2. technology type SHOULD be placed immediately after assay name\n3. comment[data file] is RECOMMENDED as the last column\n\nAssay Name\n\nColumn\n\nassay name\n\nDescription\n\nAssay name is a unique identifier for an MS run (data file). Each distinct MS run/data file MUST have exactly one globally unique assay name, and no two different data files may share an assay name.\n\nUniqueness Rules\n\n The combination of source name + assay name + comment[label] MUST be unique within the SDRF file.\n\nRule |Requirement |Description\n\nassay name uniqueness\nMUST\nEach data file has exactly one unique assay name\n\nsource name + assay name\nRECOMMENDED\nShould be unique (warning if not)\n\nsource name + assay name + comment[label]\nMUST\nRequired unique combination\n\nExamples\n\nFormat |Example |Use Case\n\nsamplerun\nsample1run1\nSimple naming\n\nsamplefractionreplicate\ns",
    "url": "./conventions/data-file-metadata.html",
    "section": "Data File Metadata Convention",
    "keywords": "sample SCIEX instrument SRM SILAC precursor mass tolerance fraction cleavage agent details MUST UNIMOD:4 PP RAW TMT MSD SHOULD LTQ PRIDE:0000663 MS:1001309 UNIMOD:35 file uri MS2 analyzer type MS MM KR TOF RECOMMENDED MRM DDA UNIMOD UNIMOD:737 RPPA scan window upper limit exclamation CF FTP REQUIRED MOD PSI UNIMOD:21 IMPORTANT MT label AC UNIMOD:1 MS:1001313 PRM fragment mass tolerance ST modification parameters XL CS fraction identifier MS:1001917 SDRF scan window lower limit ELISA PRIDE technical replicate NT DIA TIP ID NOTE data file MS:1001251 proteomexchange accession number MS:1001303 MGF HF TA URI MS:1001306 TS URL proteomics data acquisition method MS1 scan range"
  },
  {
    "title": "Data File Metadata Conventions",
    "content": "Data File Metadata Conventions\n\nStatus of this Convention\n\nThis document provides guidelines for annotating data file metadata in SDRF-Proteomics format. These conventions define standardized approaches for describing MS run files, instrument settings, and analysis parameters.\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nData file metadata conventions define standardized formats for properties that describe the relationship between samples and data files, instrument configurations, and analysis parameters. This convention covers:\n\n- Assay name and data file identification\n- Label annotations for multiplexed experiments\n- Instrument type and model\n- Technology type\n- Protein modifications\n- Cleavage agents\n- Mass tolerances\n\nFor sample metadata conventions (organism, age, sex, disease), see Sample Metadata Conventions.\n\nCore Data File Columns\n\nThe connection between samples and data files is done using properties annotated with the comment prefix. The use of comment differentiates data file properties from sample properties (characteristics).\n\nColumn Order\n\nThe order of columns is important:\n\n1. assay name SHOULD always be located before the comments\n2. technology type SHOULD be placed immediately after assay name\n3. comment[data file] is RECOMMENDED as the last column\n\nAssay Name\n\nColumn\n\nassay name\n\nDescription\n\nAssay name is a unique identifier for an MS run (data file). Each distinct MS run/data file MUST have exactly one globally unique assay name, and no two different data files may share an assay name.\n\nUniqueness Rules\n\n The combination of source name + assay name + comment[label] MUST be unique within the SDRF file.\n\nRule |Requirement |Description\n\nassay name uniqueness\nMUST\nEach data file has exactly one unique assay name\n\nsource name + assay name\nRECOMMENDED\nShould be unique (warning if not)\n\nsource name + assay name + comment[label]\nMUST\nRequired unique combination\n\nExamples\n\nFormat |Example |Use Case\n\nsamplerun\nsample1run1\nSimple naming\n\nsamplefractionreplicate\ns",
    "url": "./conventions/data-file-metadata.html#data-file-metadata-conventions",
    "section": "Data File Metadata Convention",
    "keywords": "SCIEX instrument SRM SILAC precursor mass tolerance cleavage agent details MUST UNIMOD:4 PP RAW TMT MSD SHOULD LTQ PRIDE:0000663 MS:1001309 UNIMOD:35 file uri MS2 analyzer type MS MM KR TOF RECOMMENDED MRM DDA UNIMOD UNIMOD:737 RPPA scan window upper limit CF FTP REQUIRED MOD PSI UNIMOD:21 MT label AC UNIMOD:1 MS:1001313 PRM fragment mass tolerance ST modification parameters XL CS fraction identifier MS:1001917 SDRF scan window lower limit ELISA PRIDE technical replicate NT DIA ID proteomexchange accession number data file MS:1001251 MS:1001303 MGF HF TA URI MS:1001306 TS URL proteomics data acquisition method MS1 scan range"
  }
]